CEACAM5 and neoplasm: Sex, histology, tumor location, T stage, adjuvant therapy, pathological grading, venous/perineural invasion, preoperative carcinoembryonic antigen (CEA) level, and MMR (Mismatch Repair) status in the training cohort and validation cohort are shown in Table 1.